MREO   $1.23  2.48% Market Closed

Mereo Biopharma Group PLC
Total Cash 87.43M
totalCashPerShare 0.114
EBITDA -37.31M
Total Debt 6.16M
quickRatio 5.784
currentRatio 6.074
Total Revenue 1.00M
debtToEquity 7.835
Revenue/Share 0.007
ROA -0.23857
ROE -0.48473
grossProfits
freeCashflow -15.37M
operatingCashflow -20.02M
earningsGrowth
revenueGrowth
grossMargins 1.509
ebitdaMargins 0.0
operatingMargins -37.904
profitMargins 0.0
enterpriseValue 3.41B
forwardPE -151.35667
floatShares 485.07M
sharesOutstanding 153.85M
sharesShort 4.88M
sharesShortPriorMonth 4.50M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.65%
Short Ratio help_outline 6.19%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.512
Price To Book help_outline 8.87
earningsQuarterlyGrowth
netIncomeToCommon -36.85M
trailingEps -0.25%
forwardEps -0.03%
enterpriseToEbitda -91.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.02 3Q 2024
institutionsCount 87
lastUpdated Oct. 16, 2024, 7:09 p.m.